All In Biotech

Drug Trial Radar · NCT07919405

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) in Participants With Hypertension and Obesity

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 1,408 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

1,408

Planned (sponsor's estimate)

Start

Nov 11, 2026

Primary completion

Jun 1, 2028

Study completion Jul 13, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Nov 5, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is testing whether CagriSema is safe and works well in adults with high blood pressure and excess body weight. Participants will receive CagriSema, semaglutide, cagrilintide, or placebo, and treatment will be assigned by chance. CagriSema and cagrilintide are investigational medicines, while semaglutide is already available by prescription.

Conditions

  • Hypertension
  • Obesity

Interventions

  • CagriSemaDrug

    CagriSema will be administered subcutaneously.

  • SemaglutideDrug

    Semaglutide will be administered subcutaneously.

  • CagrilintideDrug

    Cagrilintide will be administered subcutaneously.

  • PlaceboDrug

    Placebo will be administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CagriSema versus Placebo : Change in in-office systolic blood pressure (SBP)Time frame: From baseline (week 0) to week 32

Locations

212 sites in 19 countries. Site status is shown where the registry gives one.

  • John Muir Physicians Network

    Concord, California

  • Aurora FDRC Inc.

    Costa Mesa, California

  • Providence Medical Foundation

    Fullerton, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Desert Oasis Hlthcr Med Group

    Palm Springs, California

  • N America Res Inst - San Dimas

    San Dimas, California

  • Chase Medical Research LLC

    Waterbury, Connecticut

  • Clinical Res Of W Florida Inc

    Clearwater, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Florida Institute for Clinical research

    Orlando, Florida

  • Javara Inc. / Privia Medical Group Georgia LLC

    Albany, Georgia

  • Hope Clin Res & Wellness

    Conyers, Georgia

  • Endocrine Research Solutions, Inc

    Roswell, Georgia

  • Javara Inc. / Privia Medical Group Georgia LLC

    Savannah, Georgia

  • Great Lakes Clinical Trials

    Chicago, Illinois

  • Koch Research

    Morton, Illinois

  • Endeavor Health

    Skokie, Illinois

  • Evanston Premier Hlthcr Res

    Skokie, Illinois

  • SIU Medicine

    Springfield, Illinois

  • Midwest Inst For Clin Res

    Indianapolis, Indiana

  • Iowa Diabetes Research

    West Des Moines, Iowa

  • Graves Gibert Clinic

    Bowling Green, Kentucky

  • Monroe Biomedical Research, LLC

    Louisville, Kentucky

  • Northern Pines Hlth Ctr, PC

    Buckley, Michigan

  • Aa Mrc Llc

    Flint, Michigan

  • StudyMetrix Research LLC

    City of Saint Peters, Missouri

  • Amicis Centers of Clinical Research

    St Louis, Missouri

  • Seacoast Kidney & Htn Specialists

    Portsmouth, New Hampshire

  • Southgate Medical Group, LLP

    West Seneca, New York

  • Great Lakes Medical Research

    Westfield, New York

  • Accellacare_NC

    Raleigh, North Carolina

  • Medication Management, LLC

    Raleigh, North Carolina

  • Piedmont Healthcare, Inc.

    Statesville, North Carolina

  • Diab & Endo Assoc of Stark Co

    Canton, Ohio

  • Family Practice Center of Wadsworth Inc.

    Wadsworth, Ohio

  • Lynn Institute of Norman

    Norman, Oklahoma

  • Clinical Res Collaborative

    Cumberland, Rhode Island

  • Coastal Carolina Res Ctr

    North Charleston, South Carolina

  • Spartanburg Medical Research

    Spartanburg, South Carolina

  • Holston Medical Group Pc

    Bristol, Tennessee

Showing 40 of 212 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.